Table 2. Frequency of autoantibodies to zinc finger proteins in patients.
Protein | Individual Specificity* | Individual Sensitivity** | Cumulative Specificity* | Cumulative Sensitivity** |
---|---|---|---|---|
ZNF346 | 94.3% (2/35) | 15.6% (15/96) | 94.3% (2/35) | 15.6% (15/96) |
ZNF638 | 97.1% (1/35) | 10.4% (10/96) | 91.4% (3/35) | 25% (24/96) |
ZNF700 | 94.3% (2/35) | 19.8% (19/96) | 91.4% (3/35) | 33.3% (32/96) |
ZNF768 | 100% (0/35) | 15.6% (15/96) | 91.4% (3/35) | 41.7% (40/96) |
* Positive for autoantibodies in non-cancer controls (NCC, n = 35)
** Positive for autoantibodies in colorectal cancer patients (CRC, n = 96)